Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy
NCT ID: NCT01856569
Last Updated: 2017-03-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
152 participants
OBSERVATIONAL
2013-07-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients
NCT07215754
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
NCT07330245
Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
NCT02926560
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
NCT04877691
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
NCT06559163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
observational
no intervention
in real life of drug,dosage,frequency and duration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
in real life of drug,dosage,frequency and duration
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unita Operativa Semplice di Reumatologia
Catania, CT, Italy
Arcispedale Sant'Anna
Ferrara, Italy, Italy
U.O.S. Reumatologia - Azienda Ospedaliera Universitaria Policlinico Sant'Orsola-Malpighi
Bologna, , Italy
Piazzale Spedali Civili
Brescia, , Italy
Policlinico Di Cagliari, Dipartimento Di Scienze Mediche
Cagliari, , Italy
Via Torregalli, 3
Florence, , Italy
Ospedale Ortopedico G. Pini
Milan, , Italy
Fondazione San Raffaele del Monte Tabor
Milan, , Italy
Policlinico Universitario, II Universita
Napoli, , Italy
Policlinico Universitario
Padua, , Italy
Divisione di Reumatologia
Palermo, , Italy
Policlinico Universitario P. Giaconne
Palermo, , Italy
Azienda USL 4 di Prato
Prato, , Italy
Università Campus Bio-Medico di Roma- Policlinico Universitario Campus Bio-medico di Roma
Roma, , Italy
Policlinico Umberto I
Roma, , Italy
Ospedale Mauriziano Umberto I
Torino, , Italy
Policlinico Universitario
Udine, , Italy
Ospedale Borgo Trento - Clinica Reumatologica
Verona, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1801362
Identifier Type: -
Identifier Source: secondary_id
B1801362
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.